Impact of semaglutide on high-sensitivity c-reactive protein: exploratory patient-level analyses of sustain and pioneer randomized clinical trials

HIGHLIGHTS

• who: Ofri Mosenzon from the Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, PO have published the research: Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials, in the Journal: (JOURNAL)
• what: The aim of this exploratory analysis was to evaluate the effect of semaglutide on hsCRP, and the contribution of glucose control and weight loss to this effect, in subjects at different stages of type 2 diabetes. In this analysis, potential mediators for change in hsCRP, adjusted for possible confounders, were investigated . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.